Table 6 Likelihood ratio test of the neuro-glymphatic model versus the null modela

From: The glymphatic system clears amyloid beta and tau from brain to plasma in humans

Condition and Predictor

Amyloid Status

Model

AIC

BIC

logLik

LRT

DF

P

Sleep Condition, PhysioS

Positive

Null

396.0

422.1

−185.0

   

Model

362.9

401.0

−162.4

45.2

6

<0.001

Negative

Null

814.5

880.6

−384.2

   

Model

735.4

830.2

−334.7

99.1

10

<0.001

Sleep Condition, HypnoS

Positive

Null

396.0

422.1

−185.0

   

Model

381.4

419.5

−171.7

26.6

6

<0.001

Negative

Null

814.5

880.6

−384.2

   

Model

741.6

836.5

−337.8

92.9

10

<0.001

Sleep Deprivation/Wake PhysioW

Positive

Null

337.4

360.9

−155.7

   

Model

281.0

315.3

−121.5

68.4

6

<0.001

Negative

Null

688.6

751.8

−321.3

   

Model

623.5

714.1

−278.8

85.1

10

<0.001

  1. aAIC, Akaike Information Criteria; BIC, Bayesian Information Criteria; logLik, log likelihood; LRT, log likelihood ratio; DF, degrees of freedom; P, p-value; PhysioS and PhysioW, single predictors constructed from the linear combination of the full model predictors during the sleep and sleep deprivation (wake) conditions, respectively, for both amyloid positive and negative participants separately; HypnoS, single predictor constructed from the full model hypnogram features during the sleep condition for both amyloid positive and negative participants separately. Two-sided p-values were calculated using a likelihood ratio test, with p-values derived from a chi-squared distribution. Degrees of freedom corresponded to the number of additional parameters in the more complex model. No adjustments were made for multiple comparisons. Bolded P values reflect significant LRT at P < 0.05.